You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
30 July 2026 - Stevanato Group S.p.A. (NYSE:STVN), a provider of drug containment, drug delivery and diagnostic solutions for the pharmaceutical, biotechnology and life sciences industries, announced on Thursday that liraglutide-based combination pro...
30 July 2026 - Life science technology company 10x Genomics Inc (Nasdaq:TXG) on Wednesday announced a research collaboration with Lausanne University Hospital (CHUV), a Swiss academic medical centre, to advance research in diagnostic applications of ...
29 July 2026 - US biopharmaceutical company AbbVie (NYSE: ABBV) said on Wednesday it has received European Commission approval for RINVOQ (upadacitinib) to treat adults and adolescents aged 12 and over with severe alopecia areata when taken once dail...
29 July 2026 - Clinical-stage biotechnology company AbCellera Biologics Inc (Nasdaq:ABCL) announced on Wednesday that it has entered into a collaboration with biopharmaceutical company Vertex Pharmaceuticals Incorporated (Nasdaq:VRTX) to research, de...
29 July 2026 - Biopharmaceutical company Incyte (Nasdaq:INCY) announced on Wednesday that the European Commission has approved Opzelura (ruxolitinib) cream for adults with moderate atopic dermatitis who have an inadequate response to or cannot use to...
29 July 2026 - Biopharmaceutical company Synlogic Inc (OTC:SYBX) and Caldera Therapeutics Inc, a privately held clinical-stage biotechnology company announced on Wednesday that they have entered into a definitive an all-stock merger agreement to comb...
29 July 2026 - Biopharmaceutical group Hemogenyx Pharmaceuticals plc (LSE: HEMO) reported on Wednesday that it has signed a letter of intent with the National Cancer Centre at Vilnius University Hospital Santaros Klinikos to establish a scientific an...